Clinical efficacy and safety of Dupilumab for the treatment of moderate to severe atopic dermatitis in Korea

被引：0
|
作者：
Kim, Jongwook [1 ]
Kim, Yeona [1 ]
Won, Sang-Hyeon [1 ]
Bae, Kyung-Nam [1 ]
Lee, Jungsoo [1 ]
Shin, Kihyuk [1 ]
Kim, Hoonsoo [1 ]
Ko, Hyunchang [1 ]
Kim, Moon-Bum [1 ]
Kim, Byungsoo [1 ]
机构：
[1] Pusan Natl Univ, Busan, South Korea
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2023年 / 89卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
42002
引用
收藏
页码：AB136 / AB136
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [2] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    [J]. ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [3] Retrospective Study of Dupilumab Treatment for Moderate to Severe Atopic Dermatitis in Korea: Efficacy and Safety of Dupilumab in Real-World Practice
    Jang, Dong Hyek
    Heo, Seok Jae
    Jung, Hye Jung
    Park, Mi Yeon
    Seo, Seong Jun
    Ahn, Jiyoung
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 12
  • [4] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    [J]. ALLERGY, 2019, 74 : 182 - 182
  • [5] Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis
    Cork, M. J.
    Eichenfield, L. F.
    Blauvelt, A.
    Rosmarin, D.
    Hussain, I.
    Davis, J. D.
    Li, M.
    Zhang, Q.
    Gadkari, A.
    Eckert, L.
    Kamal, M. A.
    Bansal, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S104 - S104
  • [6] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Dong Hyek Jang
    Seok Jae Heo
    Hyung Don Kook
    Dong Heon Lee
    Hye Jung Jung
    Mi Yeon Park
    Jiyoung Ahn
    [J]. Scientific Reports, 11
  • [7] A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
    Jang, Dong Hyek
    Heo, Seok Jae
    Kook, Hyung Don
    Lee, Dong Heon
    Jung, Hye Jung
    Park, Mi Yeon
    Ahn, Jiyoung
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Dupilumab in the treatment of moderate-to-severe atopic dermatitis
    Kraft, Magdalena
    Worm, Margitta
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (04) : 301 - 310
  • [9] Dupilumab Efficacy and Safety in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Case Series
    Mareschal, Adrien
    Puzenat, Eve
    Aubin, Francois
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 (01)
  • [10] Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience
    Martinez-Domenech, A.
    Zaragoza-Ninet, V.
    Esteve-Martinez, A.
    Garcia-Rabasco, A.
    Sanchez-Carazo, J. L.
    Perez-Ferriols, A.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2024, 115 (02): : 150 - 158
12345